Application areas of the ArthroTarget platform
The ArthroTarget platform is being developed for indications where locally addressable drug delivery provides a clear functional advantage over systemic therapies. The focus is on diseases with spatially confined pathologies and a high demand for precise, controlled drug dosing.
The primary development focus currently lies on joint-related diseases, particularly osteoarthritis, where locally confined degenerative processes allow for targeted therapeutic intervention.
Beyond this, the application potential of the platform is scientifically evaluated in additional areas:
Cartilage and bone diseases
Degenerative or trauma-related conditions of the musculoskeletal system where localized drug release may be advantageous.
Tissue damage and regenerative processes
Support of healing and regeneration mechanisms in structurally damaged tissues.
Organ-related localized indications
Exploratory evaluation of application scenarios with clearly definable target regions.
Oncological applications
Prospective investigation of the potential of locally addressable drug delivery systems to support targeted tumor therapies.
The listed application areas are part of ongoing research and development activities. Current experimental results and technical details are not publicly disclosed for reasons of intellectual property protection. These are not clinically approved therapies; further disclosure is planned following completion of appropriate protection and regulatory processes.
